Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2025–2026

NACI recommends that seasonal influenza vaccine should be offered annually to anyone six months of age and older who does not have a contraindication to the vaccine. Influenza vaccination is particularly important for people at high risk of influenza-related complications or hospitalization, people capable of transmitting influenza to those at high risk, and others as outlined in the Statement.

Authors

Institutions

Publication Details

Journal
Canada Communicable Disease Report
Published
2025-10-09
DOI
https://doi.org/10.14745/ccdr.v51i09a01
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2025–2026

Winnie Siu, Angela Sinilaité, Katarina Gusić, Jesse Papenburg
Canada Communicable Disease Report
Influenza Virus Research Studies
article

Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2025–2026

Winnie Siu, Angela Sinilaité, Katarina Gusić, Jesse Papenburg
article en

Abstract

NACI recommends that seasonal influenza vaccine should be offered annually to anyone six months of age and older who does not have a contraindication to the vaccine. Influenza vaccination is particularly important for people at high risk of influenza-related complications or hospitalization, people capable of transmitting influenza to those at high risk, and others as outlined in the Statement.

Canada Communicable Disease ReportVol. 51(9)
University of Ottawa (CA), Public Health Agency of Canada (CA), Montreal Children's Hospital (CA), McGill University Health Centre (CA), National Influenza Center (MN), McGill University (CA)
Public Health Agency of Canada, Public Health Agency, Indigenous Services Canada, Centers for Disease Control and Prevention, Health Canada
Openalex Percentile: Top 62%
Influenza Virus Research Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2025–2026 — Winnie Siu, Angela Sinilaité, et al. · Canada Communicable Disease Report (2025) | TGRS Research Map | TGRS